Dr. Martens plc (LON:DOCS)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 898.76M |
| Revenue (ttm) | 787.60M |
| Net Income (ttm) | 4.50M |
| Shares Out | 966.41M |
| EPS (ttm) | 0.00 |
| PE Ratio | 198.89 |
| Forward PE | 21.64 |
| Dividend | 0.03 (2.74%) |
| Ex-Dividend Date | Aug 28, 2025 |
| Volume | 274,857 |
| Average Volume | 1,285,095 |
| Open | 93.95 |
| Previous Close | 93.00 |
| Day's Range | 91.10 - 93.95 |
| 52-Week Range | 43.02 - 100.87 |
| Beta | 0.24 |
| RSI | 52.78 |
| Earnings Date | Nov 20, 2025 |
About Dr. Martens
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom. [Read more]
Financial Performance
In 2024, Dr. Martens's revenue was 787.60 million, a decrease of -10.20% compared to the previous year's 877.10 million. Earnings were 4.50 million, a decrease of -93.50%.
Financial StatementsNews
Bank of England finance chief Afua Kyei tops list of influential black Britons
Kyei leads power list showcasing black role models across business, science, technology and the arts Afua Kyei, the finance chief of the Bank of England, has been named the UK’s most influential black...
Dr. Martens: Iconic Brand At A Potential Bargain
Dr. Martens remains profitable despite recent challenges, with a strong brand moat and loyal customer base supporting its long-term investment case. Cost-cutting, improved inventory control, and a con...
Dr. Martens plc (DOCMF) Q4 2025 Earnings Conference Call Transcript
Dr. Martens plc (OTCPK:DOCMF) Q4 2025 Earnings Conference Call June 5, 2025 2:00 AM ET Company Participants Giles Wilson - CFO & Director Onyeije Ogueri Nwokorie - CEO & Chief Brand Officer Onyeije Og...
Dr Martens forecasts return to profit growth, shares jump
British bootmaker Dr Martens forecast a return to profit growth in the current financial year on Thursday, backed by its new CEO's plan to put more emphasis on shoes, sandals, and bags, as well as the...
Dr. Martens Selects Amperity to Transform Customer Data Strategy
LONDON--(BUSINESS WIRE)-- #AdTech--Amperity, an AI-powered customer data cloud, today announced Dr. Martens, an iconic British brand, has selected its platform to support its global data and marketing...
Dr. Martens plc (DOCMF) Q3 2025 Sales/ Trading Statement Call Transcript
Dr. Martens plc (OTCPK:DOCMF) Q3 2025 Sales/ Trading Statement Call January 27, 2025 4:00 AM ET Company Participants Ije Nwokorie - CEO Giles Wilson - CFO Conference Call Participants Kate Calvert - I...
Dr Martens' shares jump 15% on new CEO's start date despite drop in first half sales
Dr Martens said its new CEO Ije Nwokorie will take over from incumbent Kenny Wilson on Jan. 6 2025, in a shakeup investors hope could boost the struggling boot maker
Dr Martens sees strong US holiday sales, cuts inventory and debt
Dr Martens said on Thursday that the autumn-winter festive season had got off to an encouraging start and investors welcomed a reduction in net debt as the bootmaker tries to turn its performance arou...
Stock Picks From Seeking Alpha's October 2024 New Analysts
In October, 42 new analysts joined Seeking Alpha, sharing diverse investment ideas and strategies, from biotech to real estate. Highlighted strong buy recommendations include MicroStrategy, CorMedix, ...
Dr. Martens: Struggling To See The Downside At This Valuation
Dr. Martens is a strong brand with healthy cash flows and a cheap valuation, making it an attractive investment opportunity. Growth potential lies in geographic expansion and product line diversificat...
Dr. Martens shares plunge to record lows on discount bulk sale via Goldman Sachs
Dr. Martens' investors sold 70 million shares in the bootmaker at a price of 57.85 pence per share, in what marks a 10% discount on its closing share price on Thursday
Dr. Martens plc. (DOCMF) H2 2024 Earnings Call Transcript
Dr. Martens plc. (OTCPK:DOCMF) H2 2024 Earnings Conference Call May 30, 2024 4:30 AM ET Corporate Participants Kenneth Wilson - Chief Executive Officer Giles Wilson - Chief Financial Officer Conferenc...
Dr Martens will cut up to £25m in costs to counter weak US sales
British footwear brand does not rule out job losses, while profits fall by 43% to £97m
Dr. Martens Stock Plummets on Downbeat US Outlook
U.K.-listed Dr. Martens PLC issued a downbeat outlook for its U.S. sales on Tuesday, noting that it expects wholesale revenue in the country to be down by double digits for its fiscal 2025 year, and s...
Dr. Martens' profit warning highlights U.S. consumer-confidence challenge
Dr. Martens' profit warning sent shares of the iconic shoe brand tumbling Tuesday and spotlighted consumer-spending challenges on both sides of the Atlantic.
Dr. Martens Shares Tumble as Bootmaker Warns of Tough Year
Dr. Martens shares plummeted after the iconic British footwear and clothing brand said Chief Executive Officer Kenny Wilson plans to step down and warned of a challenging year ahead.
Dr. Martens shares lose a third of their value on U.S. warning
Shares of iconic shoe brand Dr. Martens fell as much as 32% on Tuesday with the company's U.S. business going so badly it needs to extend paying for additional storage space as it announced its chief ...
Dr. Martens shares plunge 30% to all-time low, trading briefly halted on weak outlook
Shares of Dr. Martens plunged to a record low in early deals after the shoemaker flagged a challenging 2025 outlook.
Bootmaker Dr Martens names new CEO, flags tough year on weak demand
British bootmaker Dr Martens named its chief brand officer Ije Nwokorie as its next CEO on Tuesday, saying Kenny Wilson had decided this year would be his final year as top boss.
Exclusive: Marathon Partners pushes Dr. Martens for strategic review, possible sale
Investment firm Marathon Partners Equity Management wants British boot maker Dr. Martens to hire bankers and begin an immediate strategic review that could lead to a sale of the company, according to ...
Dr. Martens: A Value Play With High Yield Worth Digging Into
Dr. Martens aims to become a £2 billion revenue company by focusing on direct-to-consumer sales, global expansion, and increasing online sales. The company has a strong brand with steady brand awarene...
Dr. Martens' Headwinds Have Created An Undervalued Growth Story
Dr. Martens' stock has lost the majority of its value as economic headwinds have halted the company's growth for the time being. The company continues to have quite strong margins, and I believe the l...
Dr Martens' revenue plummets by a fifth as US sales plunge
Bootmaker says global sales fell by 18%, with cash-strapped consumers refusing to splash out at Christmas
Bootmaker Dr Martens hit by weak December as US sales slide
Britain's Dr Martens said its visibility over wholesale orders "remains weak" as the bootmaker posted a drop in third-quarter revenue on Thursday following several profit warnings and a disappointing ...
Dr. Martens: Don't Miss This Opportunity
Dr. Martens stock has plummeted over 80% since its IPO in early 2021, but the company's earnings and financials remain strong. H1 FY2024 disappointed, but long-term growth remains. The company is unde...